- Home
- OCGN vs RPT Comparison
OCGN vs RPT Comparison
Compare OCGN & RPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- RPT
- Stock Information
- Founded
- OCGN 2013
- RPT 2014
- Country
- OCGN United States
- RPT United States
- Employees
- OCGN N/A
- RPT N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- RPT
- Sector
- OCGN Health Care
- RPT
- Exchange
- OCGN Nasdaq
- RPT NYSE
- Market Cap
- OCGN 189.6M
- RPT 156.7M
- IPO Year
- OCGN N/A
- RPT N/A
- Fundamental
- Price
- OCGN $0.70
- RPT $2.87
- Analyst Decision
- OCGN Strong Buy
- RPT Strong Buy
- Analyst Count
- OCGN 3
- RPT 1
- Target Price
- OCGN $6.33
- RPT $4.00
- AVG Volume (30 Days)
- OCGN 4.2M
- RPT 232.6K
- Earning Date
- OCGN 03-05-2025
- RPT 01-01-0001
- Dividend Yield
- OCGN N/A
- RPT 8.39%
- EPS Growth
- OCGN N/A
- RPT N/A
- EPS
- OCGN N/A
- RPT N/A
- Revenue
- OCGN $4,054,999.00
- RPT N/A
- Revenue This Year
- OCGN N/A
- RPT N/A
- Revenue Next Year
- OCGN N/A
- RPT N/A
- P/E Ratio
- OCGN N/A
- RPT N/A
- Revenue Growth
- OCGN N/A
- RPT N/A
- 52 Week Low
- OCGN $0.52
- RPT $2.65
- 52 Week High
- OCGN $2.08
- RPT $3.94
- Technical
- Relative Strength Index (RSI)
- OCGN 53.03
- RPT N/A
- Support Level
- OCGN $0.69
- RPT N/A
- Resistance Level
- OCGN $0.80
- RPT N/A
- Average True Range (ATR)
- OCGN 0.05
- RPT 0.00
- MACD
- OCGN 0.02
- RPT 0.00
- Stochastic Oscillator
- OCGN 58.35
- RPT 0.00
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About RPT RITHM PROPERTY TRUST INC
Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.